EP PerMed grant awarded to European consortium led by Sigrid S. Skånland at Institute for Cancer Research
A European consortium coordinated by Sigrid S. Skånland, project group leader at the Department of Cancer Immunology, has been awarded an EP PerMed grant co-funded by the European Commission for their project “Chronic lymphocytic leukemia: Improving survival and quality of life (CLL-OUTCOME)”.
The vision of the European Partnership for Personalised Medicine is to “improve health outcomes within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens, and society”.